Supriya Lifescience Limited (SUPRIYA.NS)

INR 698.8

(3.55%)

Net Income Summary of Supriya Lifescience Limited

  • Supriya Lifescience Limited's latest annual net income in 2023 was 1.19 Billion INR , up 32.56% from previous year.
  • Supriya Lifescience Limited's latest quarterly net income in 2024 Q2 was 461.49 Million INR , up 3.37% from previous quarter.
  • Supriya Lifescience Limited reported an annual net income of 898.57 Million INR in 2022, down -40.81% from previous year.
  • Supriya Lifescience Limited reported an annual net income of 1.51 Billion INR in 2021, up 22.83% from previous year.
  • Supriya Lifescience Limited reported a quarterly net income of 446.44 Million INR for 2024 Q1, up 20.88% from previous quarter.
  • Supriya Lifescience Limited reported a quarterly net income of 285.11 Million INR for 2023 Q1, down -25.42% from previous quarter.

Annual Net Income Chart of Supriya Lifescience Limited (2023 - 2017)

Historical Annual Net Income of Supriya Lifescience Limited (2023 - 2017)

Year Net Income Net Income Growth
2023 1.19 Billion INR 32.56%
2022 898.57 Million INR -40.81%
2021 1.51 Billion INR 22.83%
2020 1.23 Billion INR 68.38%
2019 734.03 Million INR 86.19%
2018 394.24 Million INR 351.7%
2017 87.28 Million INR 0.0%

Peer Net Income Comparison of Supriya Lifescience Limited

Name Net Income Net Income Difference
Biocon Limited 10.22 Billion INR 88.351%
Blue Jet Healthcare Limited 1.63 Billion INR 27.259%
Concord Biotech Limited 3.08 Billion INR 61.34%
Dishman Carbogen Amcis Limited -1.53 Billion INR 177.624%
Jubilant Ingrevia Limited 1.82 Billion INR 34.871%
Lyka Labs Limited -24.89 Million INR 4884.848%
Panacea Biotec Limited -11.73 Million INR 10254.646%
Piramal Pharma Limited 178.2 Million INR -568.429%
SMS Lifesciences India Limited 90.92 Million INR -1209.982%
Syngene International Limited 5.1 Billion INR 76.644%
TAKE Solutions Limited -1.19 Billion INR 199.577%
Zota Health Care Limited -143.47 Million INR 930.184%